Benzinga's Volume Movers

Adamas Pharmaceuticals Inc ADMS shares rose 54.63 percent to $26.07. The volume of Adamas Pharmaceuticals shares traded was 4707 percent higher than normal. Adamas Pharmaceuticals reported positive top line Phase 3 results for ADS-5102. Rewalk Robotics Ltd RWLK surged 10.58 percent to $15.89. The volume of Rewalk Robotics shares traded was 466 percent higher than normal. Rewalk Robotics shares have dropped 33.66 percent over the past 52 weeks, while the S&P 500 index has declined 2.06 percent in the same period. Rovi Corporation ROVI shares moved up 35.24 percent to $15.35. The volume of Rovi traded was 453 percent higher than normal. Rovi and AT&T Inc. T reported a deal for seven-year renewal and expansion of license agreement. Celgene Corporation CELG shares climbed 7.21 percent to $119.15. The volume of Celgene shares traded was 284 percent higher than normal. Celgene has settled its REVLIMID patent litigation.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsIntraday UpdateMarketsMoversvolume movers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!